The contribution of optical coherence tomography in neurodegenerative diseases

Current Opinion in Ophthalmology

Volumn 24, Issue 6, 2013, Pages 521-527

  Simao, Luciano M ^a  

^a Avistar Clinica de Olhos   (Brazil)

Author keywords

Alzheimer's disease; Multiple sclerosis; Neuromyelitis optica; Optical coherence tomography; Parkinson's disease

Indexed keywords

BIOLOGICAL MARKER;

ACCURACY; ALZHEIMER DISEASE; DEGENERATIVE DISEASE; DISEASE COURSE; ELECTRORETINOGRAM; EYE EXAMINATION; HUMAN; MONITORING; MYELOOPTIC NEUROPATHY; NERVE DEGENERATION; NERVE FIBER; NEUROPATHOLOGY; NEUROPROTECTION; OPTICAL COHERENCE TOMOGRAPHY; PARKINSON DISEASE; PRIORITY JOURNAL; RETINA GANGLION CELL; RETINA NERVE CELL; REVIEW;

DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; HUMANS; NEURODEGENERATIVE DISEASES; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84886595287     PISSN: 10408738     EISSN: 15317021     Source Type: Journal    
DOI: 10.1097/ICU.0000000000000000     Document Type: Review

References (43)

1. Galetta KM, Calabresi PA, Frohman EM, Balcer LJ. Optical coherence tomography (OCT): Imaging the visual pathway as a model for neurodegeneration. Neurotherapeutics 2011; 8:117-132
2. Lidster K, Baker D. Optical coherence tomography detection of neurodegeneration in multiple sclerosis. CNS Neurol Disord Drug Targets 2012; 11:518-527
3. Fernandes DB, Ramos Rde I, Falcochio C, et al. Comparison of visual acuity and automated perimetry findings in patients with neuromyelitis optica or multiple sclerosis after single or multiple attacks of optic neuritis. J Neuroophthalmol 2012; 32:102-106
4. Morrow MJ, Wingerchuk D. Neuromyelitis optica. J Neuroophthalmol 2012; 32:154-166
5. Merle H, Olindo S, Donnio A, et al. Retinal peripapillary nerve fiber layer thickness in neuromyelitis optica. Invest Ophthalmol Vis Sci 2008; 49:4412-4417
6. Costello F, Coupland S, Hodge W, et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol 2006; 59:963-969
7. Naismith RT, Tutlam NT, Xu J, et al. Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology 2009; 72:1077-1082
8. Nakamura M, Nakazawa T, Doi H, et al. Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica. Graefes Arch Clin Exp Ophthalmol 2010; 248:1777-1785
9. Noval S, Contreras I, Munoz S, et al. Optical coherence tomography in multiple sclerosis and neuromyelitis optica: An update. Mult Scler Int 2011; 2011:472790
10. Ratchford JN, Quigg ME, Conger A, et al. Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology 2009; 73:302-308
11. de Seze J, Blanc F, Jeanjean L, et al. Optical coherence tomography in neuromyelitis optica. Arch Neurol 2008; 65:920-923
12. Simao LM. Neuromyelitis optica antibody in Leber hereditary optic neuropathy: Case report. Arq Bras Oftalmol 2012; 75:280-282
13. Monteiro ML, Fernandes DB, Apostolos-Pereira SL, Callegaro D. Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optic neuritis using Fourier-domain optical coherence tomography. Invest Ophthalmol Vis Sci 2012; 53:3959-3966
14. Fernandes DB, Raza AS, Nogueira RG, et al. Evaluation of inner retinal layers in patients with multiple sclerosis or neuromyelitis optica using optical coherence tomography. Ophthalmology 2013; 120:387-394
15. Sotirchos ES, Saidha S, Byraiah G, et al. In vivo identification of morphologic retinal abnormalities in neuromyelitis optica. Neurology 2013; 80:1406-1414
16. Pfueller CF, Paul F. Imaging the visual pathway in neuromyelitis optica. Mult Scler Int 2011; 2011:869814
17. Bouyon M, Collongues N, Zephir H, et al. Longitudinal follow-up of vision in a neuromyelitis optica cohort. Mult Scler 2013; 19:1320-1322
18. Guo L, Duggan J, Cordeiro MF. Alzheimer's disease and retinal neurodegeneration. Curr Alzheimer Res 2010; 7:3-14
19. Kirbas S, Turkyilmaz K, Anlar O, et al. Retinal nerve fiber layer thickness in patients with Alzheimer disease. J Neuroophthalmol 2013; 33:58-61
20. Ohno-Matsui K. Parallel findings in age-related macular degeneration and Alzheimer's disease. Prog Retin Eye Res 2011; 30:217-238
21. Oliveira LT, Louzada PR, de Mello FG, Ferreira ST. Amyloid-beta decreases nitric oxide production in cultured retinal neurons: A possible mechanism for synaptic dysfunction in Alzheimer's diseasé Neurochem Res 2011; 36:163-169
22. Hinton DR, Sadun AA, Blanks JC, Miller CA. Optic-nerve degeneration in Alzheimer's disease. N Engl J Med 1986; 315:485-487
23. Katz B, Rimmer S. Ophthalmologic manifestations of Alzheimer's disease. Surv Ophthalmol 1989; 34:31-43
24. Krasodomska K, Lubinski W, Potemkowski A, Honczarenko K. Pattern electroretinogram (PERG) and pattern visual evoked potential (PVEP) in the early stages of Alzheimer's disease. Doc Ophthalmol 2010; 121:111-121
25. Paquet C, Boissonnot M, Roger F, et al. Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett 2007; 420:97-99
26. Moschos MM, Markopoulos I, Chatziralli I, et al. Structural and functional impairment of the retina and optic nerve in Alzheimer's disease. Curr Alzheimer Res 2012; 9:782-788
27. Parisi V, Restuccia R, Fattapposta F, et al. Morphological and functional retinal impairment in Alzheimer's disease patients. Clin Neurophysiol 2001; 112:1860-1867
28. Berisha F, Feke GT, Trempe CL, et al. Retinal abnormalities in early Alzheimer's disease. Invest Ophthalmol Vis Sci 2007; 48:2285-2289
29. Armstrong RA. Visual field defects in Alzheimer's disease patients may reflect differential pathology in the primary visual cortex. Optom Vis Sci 1996; 73:677-682
30. Chi Y, Wang YH, Yang L. The investigation of retinal nerve fiber loss in Alzheimer's disease. Zhonghua Yan Ke Za Zhi 2010; 46:134-139
31. Iseri PK, Altinas O, Tokay T, Yuksel N. Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol 2006; 26:18-24
32. Kesler A, Vakhapova V, Korczyn AD, et al. Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Clin Neurol Neurosurg 2011; 113:523-526
33. Djamgoz MB, Hankins MW, Hirano J, Archer SN. Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vision Res 1997; 37:3509-3529
34. Altintas O, Iseri P, Ozkan B, Caglar Y. Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease. Doc Ophthalmol 2008; 116:137-146
35. Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A. Retinal nerve fiber layer thinning in Parkinson disease. Vision Res 2004; 44:2793-2797
36. Moschos MM, Tagaris G, Markopoulos I, et al. Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur J Ophthalmol 2011; 21:24-29
37. Aaker GD, Myung JS, Ehrlich JR, et al. Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography. Clin Ophthalmol 2010; 4:1427-1432
38. Shrier EM, Adam CR, Spund B, et al. Interocular asymmetry of foveal thickness in Parkinson disease. J Ophthalmol 2012; 2012:728457
39. Hajee ME, March WF, Lazzaro DR, et al. Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol 2009; 127:737-741
40. Rohani M, Langroodi AS, Ghourchian S, et al. Retinal nerve changes in patients with tremor dominant and akinetic rigid Parkinson's disease. Neurol Sci 2012; 34:689-693
41. Adam CR, Shrier E, Ding Y, et al. Correlation of inner retinal thickness evaluated by spectral-domain optical coherence tomography and contrast sensitivity in Parkinson disease. J Neuroophthalmol 2013; 33:137-142
42. Spund B, Ding Y, Liu T, et al. Remodeling of the fovea in Parkinson disease. J Neural Transm 2013; 120:745-753
43. Kirbas S, Turkyilmaz K, Tufekci A, Durmus M. Retinal nerve fiber layer thickness in Parkinson disease. J Neuroophthalmol 2013; 33:62-65